Novavax COVID-19 vaccine could be approved very soon, says EMA chief

Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Novavax logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic

BRUSSELS, Dec 7 (Reuters) – (This December 7 story corrected first name of EMA head in paragraph 2)

The head of the European Medicines Agency (EMA) on Tuesday said that it could soon approve the COVID-19 vaccine developed by U.S. biotech company Novavax (NVAX.O).

“The vaccine from Novavax could be authorised in the very near future,” Emer Cooke told EU health ministers during a public session of a meeting in Brussels.

Reporting by Francesco Guarascio
Editing by David Goodman

Our Standards: The Thomson Reuters Trust Principles.